TR201906107T4 - Dotap klorürün stabil kristal modifikasyonlarının hazırlanması. - Google Patents
Dotap klorürün stabil kristal modifikasyonlarının hazırlanması.Info
- Publication number
- TR201906107T4 TR201906107T4 TR2019/06107T TR201906107T TR201906107T4 TR 201906107 T4 TR201906107 T4 TR 201906107T4 TR 2019/06107 T TR2019/06107 T TR 2019/06107T TR 201906107 T TR201906107 T TR 201906107T TR 201906107 T4 TR201906107 T4 TR 201906107T4
- Authority
- TR
- Turkey
- Prior art keywords
- preparation
- crystal modifications
- stable crystal
- dotap chloride
- dotap
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
- C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/08—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to an acyclic carbon atom of an acyclic unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Liquid Crystal Substances (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bu buluş, rasemik (2R,S)- ve enantiomerik olarak saf (2R) ve (2S)-DOTAP klorürün kristal modifikasyonlarıyla, bunları hazırlama amacına yönelik proseslerle ve bunların farmasötik bileşimler hazırlamak amacıyla kullanılmasıyla ilgilidir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488428P | 2011-05-20 | 2011-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201906107T4 true TR201906107T4 (tr) | 2019-05-21 |
Family
ID=46044632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/06107T TR201906107T4 (tr) | 2011-05-20 | 2012-05-02 | Dotap klorürün stabil kristal modifikasyonlarının hazırlanması. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10000445B2 (tr) |
| EP (1) | EP2709981B1 (tr) |
| JP (3) | JP6290076B2 (tr) |
| KR (1) | KR101974231B1 (tr) |
| CN (2) | CN108285422A (tr) |
| AU (1) | AU2012261276B2 (tr) |
| BR (2) | BR122021007641B8 (tr) |
| CA (1) | CA2836499C (tr) |
| ES (1) | ES2726526T3 (tr) |
| HK (1) | HK1251217A1 (tr) |
| HU (1) | HUE042949T2 (tr) |
| IL (1) | IL229146B (tr) |
| MX (1) | MX361369B (tr) |
| NO (1) | NO344225B1 (tr) |
| PL (1) | PL2709981T3 (tr) |
| PT (1) | PT2709981T (tr) |
| RU (1) | RU2627354C2 (tr) |
| SG (2) | SG194957A1 (tr) |
| TR (1) | TR201906107T4 (tr) |
| WO (1) | WO2012159704A1 (tr) |
| ZA (1) | ZA201309638B (tr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2627354C2 (ru) * | 2011-05-20 | 2017-08-07 | Мерк Патент Гмбх | Устойчивые кристаллические модификации хлорида dotap |
| KR102583917B1 (ko) * | 2014-12-08 | 2023-10-04 | 니치유 가부시키가이샤 | 양이온성 지질을 제조하는 방법 |
| CN107827762B (zh) * | 2017-11-14 | 2020-10-02 | 苏州东南药业股份有限公司 | 一种(2,3-二油酰基-丙基)三甲基氯化铵及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| DE4013632A1 (de) | 1990-04-27 | 1991-10-31 | Max Planck Gesellschaft | Liposomen mit positiver ueberschussladung |
| DE19521412A1 (de) * | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| US5869715A (en) | 1995-09-27 | 1999-02-09 | The Reagents Of The University Of California | Polyfunctional cationic cytofectins |
| US20030129223A1 (en) | 2000-10-11 | 2003-07-10 | Targesome, Inc. | Targeted multivalent macromolecules |
| AU2002953285A0 (en) * | 2002-12-12 | 2003-01-02 | Protech Research Pty Ltd | Yeast treatment |
| ITMI20032185A1 (it) | 2003-11-12 | 2005-05-13 | Chemi Spa | Processo per la sintesi di lipidi cationici. |
| DE102004057303A1 (de) * | 2004-11-26 | 2006-06-01 | Merck Patent Gmbh | Stabile Kristallmodifikationen von DOTAP Chlorid |
| RU2627354C2 (ru) * | 2011-05-20 | 2017-08-07 | Мерк Патент Гмбх | Устойчивые кристаллические модификации хлорида dotap |
-
2012
- 2012-05-02 RU RU2013156477A patent/RU2627354C2/ru active
- 2012-05-02 AU AU2012261276A patent/AU2012261276B2/en active Active
- 2012-05-02 US US14/118,571 patent/US10000445B2/en active Active
- 2012-05-02 TR TR2019/06107T patent/TR201906107T4/tr unknown
- 2012-05-02 SG SG2013084363A patent/SG194957A1/en unknown
- 2012-05-02 EP EP12719274.8A patent/EP2709981B1/en active Active
- 2012-05-02 PT PT12719274T patent/PT2709981T/pt unknown
- 2012-05-02 SG SG10201706859QA patent/SG10201706859QA/en unknown
- 2012-05-02 ES ES12719274T patent/ES2726526T3/es active Active
- 2012-05-02 WO PCT/EP2012/001882 patent/WO2012159704A1/en active Application Filing
- 2012-05-02 CN CN201810169562.7A patent/CN108285422A/zh active Pending
- 2012-05-02 CA CA2836499A patent/CA2836499C/en active Active
- 2012-05-02 BR BR122021007641A patent/BR122021007641B8/pt active Search and Examination
- 2012-05-02 PL PL12719274T patent/PL2709981T3/pl unknown
- 2012-05-02 CN CN201280024160.9A patent/CN103547560A/zh active Pending
- 2012-05-02 KR KR1020137034017A patent/KR101974231B1/ko active IP Right Grant
- 2012-05-02 BR BR112013029588-0A patent/BR112013029588B1/pt active IP Right Grant
- 2012-05-02 JP JP2014511756A patent/JP6290076B2/ja active Active
- 2012-05-02 HU HUE12719274A patent/HUE042949T2/hu unknown
- 2012-05-02 MX MX2013013403A patent/MX361369B/es active IP Right Grant
-
2013
- 2013-10-30 IL IL229146A patent/IL229146B/en active IP Right Grant
- 2013-12-18 NO NO20131703A patent/NO344225B1/no unknown
- 2013-12-19 ZA ZA2013/09638A patent/ZA201309638B/en unknown
-
2016
- 2016-12-02 JP JP2016234716A patent/JP2017075166A/ja active Pending
-
2018
- 2018-08-22 HK HK18110787.6A patent/HK1251217A1/zh unknown
- 2018-09-25 JP JP2018178658A patent/JP2018203776A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501151A1 (en) | Nrf2 regulators | |
| EA201500536A1 (ru) | Триазолопиразин | |
| EA202190619A1 (ru) | Противовирусные соединения | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| EA201992133A1 (ru) | Производные пиперидино-пиримидина для лечения вирусных инфекций | |
| EA201691216A1 (ru) | Композиции линаклотида с замедленным высвобождением | |
| AU2013225533A8 (en) | Amido spirocyclic amide and sulfonamide derivatives | |
| UA111305C2 (uk) | Конденсовані лактами арилу та гетероарилу | |
| EA201591748A1 (ru) | Модуляторы p2x7 | |
| EA201790963A1 (ru) | Противовирусные соединения | |
| IN2015DN03029A (tr) | ||
| MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
| EA201590887A1 (ru) | Композиция | |
| EA201400976A1 (ru) | Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена | |
| MX2013004061A (es) | Analogos de ciclosporina. | |
| EA201590272A1 (ru) | Пероральные дозированные формы для модифицированного высвобождения, содержащие руксолитиниб | |
| EA201490037A1 (ru) | Антагонисты trpv4 | |
| TW201613864A (en) | Novel compounds | |
| UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
| GEP20186911B (en) | Substituted chroman compounds as calcium sensing receptor modulators | |
| EA201590932A1 (ru) | Композиции, содержащие вортиоксетин и донепезил | |
| EA201301061A1 (ru) | Фармацевтическая композиция, содержащая инозит | |
| MX2013004062A (es) | Analogos de ciclosporina. | |
| UA118562C2 (uk) | Модулятори рецептора cxcr7 | |
| IN2014DN09314A (tr) |